Personal Information
Organización/Lugar de trabajo
Rome Area, Italy, RM Italy
Ocupación
Co-Founder and CEO of Vaxxit Srl., Rome, Italy
Sector
Medical / Health Care / Pharmaceuticals
Sitio web
http://www.bioinnovit.com
Acerca de
A New Hope for Africa, a Serious Market Opportunity
Vaxxit Srl, of Rome, Italy (VXT) is raising €5 million to co-fund Phase III studies for registration of TatimmuneTM (scientific name: Tat vaccine), a proprietary new treatment for HIV/AIDS, in South Africa (SA). The Marketing Authorization in SA will accelerate clinical development and licensing in Europe and the USA. Data from SA are widely accepted by both agencies. HIV/AIDS is a huge problem in Africa, and in SA particularly. The SA Government spends over US$ 1.5 billion only for HIV drugs and will double that amount by 2020 to provide access to therapy to everybody infected. This effort is seriously damaged by high rates of drug fai...
Etiquetas
hiv epidemics
hiv healthcare costs
hiv in south africa
therapeutic hiv vaccine
hiv therapy
hiv drugs
art
antiretroviral therapy
immunodeficiency
aids
hiv
Ver más
Presentaciones
(1)Personal Information
Organización/Lugar de trabajo
Rome Area, Italy, RM Italy
Ocupación
Co-Founder and CEO of Vaxxit Srl., Rome, Italy
Sector
Medical / Health Care / Pharmaceuticals
Sitio web
http://www.bioinnovit.com
Acerca de
A New Hope for Africa, a Serious Market Opportunity
Vaxxit Srl, of Rome, Italy (VXT) is raising €5 million to co-fund Phase III studies for registration of TatimmuneTM (scientific name: Tat vaccine), a proprietary new treatment for HIV/AIDS, in South Africa (SA). The Marketing Authorization in SA will accelerate clinical development and licensing in Europe and the USA. Data from SA are widely accepted by both agencies. HIV/AIDS is a huge problem in Africa, and in SA particularly. The SA Government spends over US$ 1.5 billion only for HIV drugs and will double that amount by 2020 to provide access to therapy to everybody infected. This effort is seriously damaged by high rates of drug fai...
Etiquetas
hiv epidemics
hiv healthcare costs
hiv in south africa
therapeutic hiv vaccine
hiv therapy
hiv drugs
art
antiretroviral therapy
immunodeficiency
aids
hiv
Ver más